The Scientific Research Team at PIC Therapeutics is dedicated to driving the discovery and development of innovative cancer treatments by modulating RNA translation. This team conducts cutting-edge in vivo and in vitro pharmacological studies, collaborates on strategic research initiatives, and translates scientific insights into therapeutic strategies. With a diverse group of experts, they advance preclinical research to pave the way for clinical development of novel cancer therapeutics.
Dejan Juric
Scientific Advisor
Gerhard Wagner
Scientific Co-Founder, Directo...
Jennifer Petter
Scientific Advisor
Keith T. Flaherty
Scientific Advisor
Lisa Sturla
Head of In Vitro Pharmacology
Nahum Sonenberg
Scientific Advisor
Susan E. Alters
Head of In Vivo Pharmacology
Yagmur Kan
Senior Scientist
Yat Sun Or
Scientific Advisor
View all